Local drug makers win patent nullification trial over Plavix

Published: 2006-07-07 07:00:00
Updated: 2006-07-07 07:00:00
On June 28, a patent trial board ruled against Plavix (clopidogrel) patent in its nullification trial which had been sought by some local pharmaceutical firms.

Plavix is an anti-clotting agent that is the world's second-best-selling drug whose re-examination period already expired in Korea on...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.